EGFR and cancer: Mutations in the epithelial growth factor receptor (EGFR)3,4 or other receptor tyrosine kinase family members5,6, signal transducers (such as RAS)7 similarly lead to the dysregulation of MAPK pathway in many other cancer cell types.